Established in 1958, our company’s Medical Outreach Program (MMOP) is the primary mechanism through which our company donates its pharmaceuticals and vaccines for humanitarian assistance in the developing world and in support of disaster relief and emergency situations worldwide.
The program, managed by our Office of Corporate Responsibility, is one mechanism through which we help to expand access to our products, particularly in the developing world. Through this program we donate critical pharmaceuticals and vaccines to a limited number of qualified, U.S.-based nongovernmental organization (NGO) partners. The scope of the program varies from year to year and is influenced by changing medical needs in developing countries, the quantity of our medicines available for donation, and the random nature of disasters.
Donations of our medicines are made primarily through these qualified NGOs:
- Catholic Medical Mission Board (CMMB)
- Direct Relief
- IMA World Health
- MAP International
- Project HOPE
Each of these organizations has a long-standing relationship with the company; demonstrates integrity of purpose; provides assurance that our products will be securely warehoused and not diverted, mishandled or misappropriated; and has well-established programs for the ill and needy in developing countries. Through the program, we have the ability to monitor the NGOs and maintain the controls necessary for the proper distribution and handling of our medicines. We do not provide donations of expired products or of products with inadequate dating. We donate products with sufficient dating to ensure proper administration prior to expiry.
Through supply chain and facility assessments of our partners, we add value beyond our donated medicines. As of March 2015, we have completed evaluations of three of our partners and plan to complete supply chain reviews of the remaining partners by the end of 2016. Collaborative evaluations of domestic medicine warehouse facilities allow us to jointly identify improvements in medicine storage and handling to optimize supply chain effectiveness. Recommendations have included such items as regular storage-rack inspection and maintenance, strengthening of delivery receipt procedures, and improvements in material-handling procedures. We intend to continue to collaborate with our partners in ongoing reviews following the initial baseline assessment as needed.
The MMOP comprises three components:
Annual Product Allotment Program
Through this program, the NGOs with which we work can request medicines of their choice from our company’s current product line, up to an annually authorized amount. Through this approach to donations, our partners can receive a sustained and predictable supply of needed medicines, as is crucial to the effective planning of ongoing humanitarian programs.
Ongoing Donations of Pharmaceuticals & Vaccines
Donations of our pharmaceuticals and vaccines are also made in response to proposals from our partners to address some of the specific shorter-term needs of their programs around the world. We also offer products to our partners proactively, based on supply, for use in their ongoing humanitarian programs.
Disaster & Emergency Relief
Our disaster relief program is designed to provide assistance in response to major disasters and to support efforts in preparedness and recovery. We may provide donations of medicines and vaccines as well as financial support, where appropriate, through our program partners.
We are a member of the Partnership for Quality Medical Donations (PQMD), an alliance of NGOs and medical product manufacturers dedicated to raising the standards of medical donations to meet the needs of underserved populations and disaster victims around the world. In addition, we also observe the World Health Organization (WHO) Guidelines for Drug Donations. Both of these actions help to ensure and maintain the effectiveness of our donation program.
Throughout 2015, the donations of our medicines and vaccines supported vaccination programs in Tanzania and the Dominican Republic; provided disaster assistance in the U.S., the Bahamas, Malawi, Nepal and Paraguay; supported partner medical mission programs; and reached many thousands more worldwide through the ongoing medical programs of the NGOs with which we work.
|Countries and territories reached by the MMOP||82||92||86||91||72|
|People reached by the MMOP1,2||NA||NA||NA||433,624||78,555|
|Value of donations of medicines, vaccines and consumer care products (in millions)2,3,4,5||$89.8||$86.3||$69.4||$110.2||$31.1|
|Disaster relief product contributions (in millions)3||$10.4||$0.8||$2.4||$8.5||$4.7|
|1 Based on converting volume of medicines and vaccines donated in 2014. Conversion factors for this estimate were developed by IMS Health® using the U.S. product information found on our company’s product website; evidence-based factors using the IMS LifeLink® Dx, Patient Medical Claims Data, January 1, 2014, through December 31, 2014, were also developed and used for validation purposes.|
2 The decrease from 2014 to 2015 is due to a reduction in the volume of donation requests and variation in the types of products requested for donation.
3 We set the value of our product donations based on the U.S. wholesale acquisition cost.
4 Figure includes the value of product donations through the MMOP only. Product donations to ACHAP are included in the ACHAP section.
5 Effective October 1, 2014, Bayer AG purchased our company's consumer care business.